Cited by 598Protease and Inhibitor MechanismsNeuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

The DOI matches its Crossref record; 103 of the 107 references it cites were found in a registry or an index.

Matrix metalloproteinases and their multiple roles in neurodegenerative diseases

Rosenberg, Gary A·2009·The Lancet Neurology

DOI 10.1016/s1474-4422(09)70016-x

Open this paper in CoChat — free account

Abstract

Matrix metalloproteinases (MMPs) and proteins containing a disintegrin and metalloproteinase domain (ADAM) are important in neuroinflammation, and recent studies have linked their actions to neurodegenerative disorders. MMPs act as cell-surface sheddases and can affect cell signalling initiated by growth factors or death receptors. Four tissue inhibitors of metalloproteinases (TIMPs) regulate metalloproteinase activity. These proteases increase the permeability of the blood-brain barrier, which can cause oedema, haemorrhage, and cell death. MMPs also participate in tissue repair by promoting angiogenesis and neurogenesis. In vascular cognitive impairment, MMPs change permeability of the blood-brain barrier and might contribute to white matter damage. MMPs and ADAMs might contribute to the formation and degradation of amyloid proteins in Alzheimer's disease and cause death of dopaminergic neurons in Parkinson's disease. In this Review, by examining the effects of neuroinflammation, we try to understand the role that MMPs might have in neurodegenerative diseases. Therapeutic strategies that use inhibitors of MMPs could represent potential novel treatments for neurological diseases.

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(09)70016-x

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022066 · Cited by 2,313
Intracellular amyloid-β in Alzheimer's disease
LaFerla, F. M., Green, K. N., & Oddo, S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2168 · Cited by 1,942
Tissue inhibitors of metalloproteinases: evolution, structure and function
Brew, K., Dinakarpandian, D., & Nagase, H. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00279-4 · Cited by 1,932
Mechanisms, challenges and opportunities in stroke
Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003) · Nature reviews. Neuroscience · doi:10.1038/nrn1106 · Cited by 1,808
Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase
Strongin, A. Y., Collier, I. E., Bannikov, G. A., Marmer, B. L., Grant, G. A., & Goldberg, G. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5331 · Cited by 1,589
The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family.
Van Wart, H. E., & Birkedal-Hansen, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5578 · Cited by 1,475
Strategies for MMP inhibition in cancer: innovations for the post-trial era
Overall, C. M., & López-Otín, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc884 · Cited by 1,349
Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease
Girouard, H., & Iadecola, C. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00966.2005 · Cited by 1,311
VEGF enhances angiogenesis and promotes blood–brain barrier leakage in the ischemic brain
Zhang, Z. G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N. V., & Chopp, M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9369 · Cited by 1,296

Show all 107 references

Sorted by citations

Items 101–200 of 598

Mitochondrial DNA Mutation-Elicited Oxidative Stress, Oxidative Damage, and Altered Gene Expression in Cultured Cells of Patients with MERRF Syndrome
Wu, S., Ma, Y., Wu, Y., Chen, Y.-C., & Wei, Y. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8123-7 · Cited by 90
Regulation of the blood–brain barrier integrity by pericytes via matrix metalloproteinases mediated activation of vascular endothelial growth factor in vitro
Thanabalasundaram, G., Pieper, C., Lischper, M., & Galla, H. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.096 · Cited by 92
Blood-Brain Barrier Permeability Is Exacerbated in Experimental Model of Hepatic Encephalopathy via MMP-9 Activation and Downregulation of Tight Junction Proteins
Dhanda, S., & Sandhir, R. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0521-7 · Cited by 86
Plasma dilution improves cognition and attenuates neuroinflammation in old mice
Mehdipour, M., Mehdipour, T., Skinner, C. M., Wong, N., Liu, C., Chen, C.-C., Jeon, O. H., Zuo, Y., Conboy, M. J., & Conboy, I. M. (2021) · GeroScience · doi:10.1007/s11357-020-00297-8 · Cited by 77
Neuroinflammation, oxidative stress, and blood-brain barrier (BBB) disruption in acute Utah electrode array implants and the effect of deferoxamine as an iron chelator on acute foreign body response
Bennett, C., Mohammed, F. S., Álvarez-Ciara, A., Nguyen, M. A., Dietrich, W. D., Rajguru, S. M., Streit, W. J., & Prasad, A. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.040 · Cited by 87
Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer's disease
Iulita, M. F., Millón, M. B. B., Pentz, R., Aguilar, L. F., Carmo, S. D., Allard, S. T. M., Michalski, B., Wilson, E. N., Ducatenzeiler, A., Bruno, M. A., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.08.019 · Cited by 87
Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats
Zhang, Z., Zhang, Z., Wu, Y., & Schluesener, H. J. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.07.013 · Cited by 86
Development of Piperazinediones as dual inhibitor for treatment of Alzheimer's disease
Kumar, D., Gupta, S. K., Ganeshpurkar, A., Gutti, G., Krishnamurthy, S., Modi, G. P., & Singh, S. K. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.078 · Cited by 81
Contributions of Matrix Metalloproteinases to Neural Plasticity, Habituation, Associative Learning and Drug Addiction
Wright, J. W., & Harding, J. W. (2009) · Neural Plasticity · doi:10.1155/2009/579382 · Cited by 80
Matrix metalloproteinases in skeletal muscles: Friends or foes?
Alameddine, H. S. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.07.023 · Cited by 82
Heavy Metal-Induced Cerebral Small Vessel Disease: Insights into Molecular Mechanisms and Possible Reversal Strategies
Patwa, J., & Flora, S. J. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113862 · Cited by 80
Statins in neurological disorders: An overview and update
Malfitano, A. M., Marasco, G., Proto, M., Laezza, C., Gazzerro, P., & Bifulco, M. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.06.007 · Cited by 83
Proteolytic Assays on Quantum-Dot-Modified Paper Substrates Using Simple Optical Readout Platforms
Petryayeva, E., & Algar, W. R. (2013) · Analytical Chemistry · doi:10.1021/ac4020066 · Cited by 76
Cross-Talk between Glia, Neurons and Mast Cells in Neuroinflammation Associated with Parkinson’s Disease
Kempuraj, D., Selvakumar, G. P., Zaheer, S. A., Thangavel, R., Ahmed, M. E., Raikwar, S. P., Govindarajan, R., Iyer, S. S., & Zaheer, A. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9766-1 · Cited by 78
Melatonin inhibits IL1β-induced MMP9 expression and activity in human umbilical vein endothelial cells by suppressing NF-κB activation
Qin, W., Lu, W., Li, H., Yuan, X., Li, B., Zhang, Q., & Xiu, R. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0147 · Cited by 75
The emerging role of furin in neurodegenerative and neuropsychiatric diseases
Zhang, Y., Gao, X., Bai, X., Yao, S., Chang, Y., & Gao, G. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00313-1 · Cited by 80
Hepatitis B–Induced IL8 Promotes Hepatocellular Carcinoma Venous Metastasis and Intrahepatic Treg Accumulation
Zhang, C., Gao, Y., Du, C., Markowitz, G. J., Fu, J., Zhang, Z., Liu, C., Qin, W., Wang, H., Wang, F., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3453 · Cited by 72
Imaging of neuroinflammation in Alzheimer's disease, multiple sclerosis and stroke: Recent developments in positron emission tomography
Janssen, B., Vugts, D. J., Funke, U., Molenaar, G. T., Kruijer, P. S., van Berckel, B. N. M., Lammertsma, A. A., & Windhorst, A. D. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.11.011 · Cited by 77
BACE1 Dependent Neuregulin Processing: Review
Fleck, D., Garratt, A. N., Haass, C., & Willem, M. (2012) · Current Alzheimer Research · doi:10.2174/156720512799361637 · Cited by 76
Increased cerebral matrix metalloprotease‐9 activity is associated with compromised recovery in the diabetic db/db mouse following a stroke
Kumari, R., Willing, L. B., Patel, S. D., Baskerville, K. A., & Simpson, I. A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07487.x · Cited by 72
Blood–Brain Barrier Disruption and Its Involvement in Neurodevelopmental and Neurodegenerative Disorders
Aragón-González, A., Shaw, P. J., & Ferraiuolo, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315271 · Cited by 73
Oleuropein, an Anti-oxidant Polyphenol Constituent of Olive Promotes α-Secretase Cleavage of the Amyloid Precursor Protein (AβPP)
Kostomoiri, M., Fragkouli, A., Sagnou, M., Skaltsounis, L., Pelecanou, M., Tsilibary, E. C., & Tzinia, A. (2012) · Cellular and molecular neurobiology · doi:10.1007/s10571-012-9880-9 · Cited by 68
Improved Fracture Healing in Patients with Concomitant Traumatic Brain Injury: Proven or Not?
Hofman, M., Koopmans, G. C., Kobbe, P., Poeze, M., Andruszkow, H., Brink, P. R. G., & Pape, H. (2015) · Mediators of Inflammation · doi:10.1155/2015/204842 · Cited by 69
Role of P2X7 Receptors in Immune Responses During Neurodegeneration
Oliveira-Giacomelli, Á., Petiz, L. L., Andrejew, R., Turrini, N., Silva, J. B., Sack, U., & Ulrich, H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.662935 · Cited by 68
Blood-brain barrier disruption measured by albumin index correlates with inflammatory fluid biomarkers
Hillmer, L. J., Erhardt, E. B., Caprihan, A., Adair, J. C., Knoefel, J. E., Prestopnik, J., Thompson, J., Hobson, S., & Rosenberg, G. A. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221146127 · Cited by 68
Self-citation
Protease-degradable PEG-maleimide coating with on-demand release of IL-1Ra to improve tissue response to neural electrodes
Gutowski, S. M., Shoemaker, J. T., Templeman, K. L., Wei, Y., Latour, R. A., Bellamkonda, R. V., LaPlaca, M. C., & Garcı́a, A. J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.12.009 · Cited by 68
Exploring Neuroprotective Drug Therapies for Intracerebral Hemorrhage
Katsuki, H. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.10r05cr · Cited by 68
Dynamics of expression patterns of AQP4, dystroglycan, agrin and matrix metalloproteinases in human glioblastoma
Noell, S., Wolburg‐Buchholz, K., Mack, A. F., Ritz, R., Tatagiba, M. S., Beschorner, R., Wolburg, H., & Fallier‐Becker, P. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1321-4 · Cited by 66
MMPs in the Neuroretina and Optic Nerve: Modulators of Glaucoma Pathogenesis and Repair?
Groef, L. D., Hove, I. V., Dekeyster, E., Stalmans, I., & Moons, L. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13630 · Cited by 68
Glycosylation of matrix metalloproteases and tissue inhibitors: present state, challenges and opportunities
Boon, L., Ugarte-Berzal, E., Vandooren, J., & Opdenakker, G. (2016) · Biochemical Journal · doi:10.1042/bj20151154 · Cited by 68
Cells, biomarkers, and post‐traumatic stress disorder: evidence for peripheral involvement in a central disease
Andrews, J. A., & Neises, K. D. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07545.x · Cited by 68
The NGF Metabolic Pathway in the CNS and its Dysregulation in Down Syndrome and Alzheimer's Disease
Iulita, M. F., & Cuello, A. C. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150921100030 · Cited by 69
MMPs and ADAMs in neurological infectious diseases and multiple sclerosis
Muri, L., Leppert, D., Grandgirard, D., & Leib, S. L. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03174-6 · Cited by 65
Peptide-Based Selective Inhibitors of Matrix Metalloproteinase-Mediated Activities
Ndinguri, M. W., Bhowmick, M., Tokmina‐Roszyk, D., Robichaud, T. K., & Fields, G. B. (2012) · Molecules · doi:10.3390/molecules171214230 · Cited by 65
Locus Coeruleus and neurovascular unit: From its role in physiology to its potential role in Alzheimer’s disease pathogenesis
Giorgi, F. S., Galgani, A., Puglisi‐Allegra, S., Limanaqi, F., Busceti, C. L., & Fornai, F. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24718 · Cited by 69
On the Structure and functions of gelatinase B/Matrix metalloproteinase-9 in neuroinflammation
Vandooren, J., Damme, J. V., & Opdenakker, G. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63486-3.00009-8 · Cited by 65
Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer’s Disease
Janota, C. S., Lemere, C. A., & Brito, M. A. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9319-7 · Cited by 70
Analysis of Matrix Metallo-Proteases and the Plasminogen System in Mild Cognitive Impairment and Alzheimer's Disease Cerebrospinal Fluid
Hanzel, C. E., Iulita, M. F., Eyjolfsdottir, H., Hjorth, E., Schultzberg, M., Eriksdotter, M., & Cuello, A. C. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132282 · Cited by 66
The blood-brain barrier is disrupted in a mouse model of infantile neuronal ceroid lipofuscinosis: amelioration by resveratrol
Saha, A., Sarkar, C., SINGH, S. P., Zhang, Z., Munasinghe, J., Peng, S., Chandra, G., Kong, E., & Mukherjee, A. B. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds038 · Cited by 65
Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions
Donegan, R. K., & Lieberman, R. L. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00828 · Cited by 63
The role of extracellular matrix viscoelasticity in development and disease
Courbot, O., & Elósegui-Artola, A. (2025) · npj Biological Physics and Mechanics. · doi:10.1038/s44341-025-00014-6 · Cited by 77
Functional Activity of Matrix Metalloproteinases 2 and 9 in Tears of Patients With Glaucoma
Sahay, P., Rao, A., Padhy, D., Sarangi, S., Das, G., Reddy, M. M., & Modak, R. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-21723 · Cited by 61
CSF proteomics in autosomal dominant Alzheimer’s disease highlights parallels with sporadic disease
van der Ende, E. L., Veld, S. G. J. G. I. ‘., Hanskamp, I., van der Lee, S. J., Dijkstra, J. I. R., Hok‐A‐Hin, Y. S., Blujdea, E. R., Swieten, J. C. V., Irwin, D. J., Chen‐Plotkin, A. S., et al. (2023) · Brain · doi:10.1093/brain/awad213 · Cited by 59
Stromal cell-derived factor-1 and its receptor CXCR4 in adult neurogenesis after cerebral ischemia
Cui, L., Qu, H., Xiao, T., Zhao, M., Jolkkonen, J., & Zhao, C. (2013) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-120271 · Cited by 63
Regulation of matrix metalloproteinase 2 by oligomeric amyloid β protein
Li, W., Poteet, E. C., Xie, L., Liu, R., Wen, Y., & Yang, S.-H. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.078 · Cited by 61
Hypoxic-Ischaemic Encephalopathy and the Blood-Brain Barrier in Neonates
Lee, W. L. A., Michael-Titus, A. T., & Shah, D. K. (2017) · Developmental Neuroscience · doi:10.1159/000467392 · Cited by 59
Monoclonal Antibody Targeting the Matrix Metalloproteinase 9 Prevents and Reverses Paclitaxel-Induced Peripheral Neuropathy in Mice
Tonello, R., Lee, S. H., & Berta, T. (2018) · Journal of Pain · doi:10.1016/j.jpain.2018.11.003 · Cited by 60
Concentrations of matrix metalloproteinases and their tissue inhibitors in the cerebrospinal fluid of patients with Alzheimer’s disease.
Mroczko, B., Groblewska, M., Zboch, M., Kulczyńska, A., Koper, O. M., Szmitkowski, M., Kornhuber, J., & Lewczuk, P. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-131634 · Cited by 57
ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease
Letronne, F., Laumet, G. O., Ayral, A., Chapuis, J., Demiautte, F., Laga, M., Vandenberghe, M. E., Malmanche, N., Leroux, F., Eysert, F., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.06.002 · Cited by 56
A Hierarchical Structured Ultrafine Fiber Device for Preventing Postoperative Recurrence and Metastasis of Breast Cancer
Li, X., Xu, F., He, Y., Yan, L., Hou, J., Yang, G., & Zhou, S. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202004851 · Cited by 58
The matrix metalloproteinase inhibitor IPR-179 has antiseizure and antiepileptogenic effects
Broekaart, D. W. M., Bertran, A., Jia, S., Korotkov, A., Senkov, O., Bongaarts, A., Mills, J. D., Anink, J. J., Seco, J., Baayen, J. C., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138332 · Cited by 63
Vitamin D as a Potential Therapy in Amyotrophic Lateral Sclerosis
Gianforcaro, A., & Hamadeh, M. J. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12204 · Cited by 61
Changes in pain and insulin-like growth factor 1 in fibromyalgia during exercise: the involvement of cerebrospinal inflammatory factors and neuropeptides
Bjersing, J. L., Dehlin, M., Erlandsson, M. C., Bokarewa, M. I., & Mannerkorpi, K. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3902 · Cited by 59
Extracellular matrix in the CNS
Benarroch, E. E. (2015) · Neurology · doi:10.1212/wnl.0000000000002044 · Cited by 59
Role of cytokines and reactive oxygen species in brain aging
MohanKumar, S. M. J., Murugan, A., Palaniyappan, A., & MohanKumar, P. S. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111855 · Cited by 59
Matrix metalloproteinases at a glance
Hey, S., & Linder, S. (2024) · Journal of Cell Science · doi:10.1242/jcs.261898 · Cited by 55
Chemical Biology for Understanding Matrix Metalloproteinase Function
Knapinska, A. M., & Fields, G. B. (2012) · ChemBioChem · doi:10.1002/cbic.201200298 · Cited by 55
Matrix metalloproteinase-12 deficiency ameliorates the clinical course and demyelination in Theiler’s murine encephalomyelitis
Hansmann, F., Herder, V., Kalkuhl, A., Haist, V., Zhang, N., Schaudien, D., Deschl, U., Baumgärtner, W., & Ulrich, R. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0942-3 · Cited by 55
Gastrodin pretreatment alleviates rat brain injury caused by cerebral ischemic-reperfusion
Li, S., Bian, L., Fu, X., Ai, Q., Sui, Y., Zhang, A., Gao, H., Zhong, L., & Lü, D. (2019) · Brain Research · doi:10.1016/j.brainres.2019.02.006 · Cited by 55
Impact of metabolic disorders on the structural, functional, and immunological integrity of the blood‐brain barrier: Therapeutic avenues
Sheikh, M. H., Errede, M., d’Amati, A., Khan, N. Q., Fanti, S., Loiola, R. A., McArthur, S., Purvis, G. S. D., O’Riordan, C. E., Ferorelli, D., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202101297r · Cited by 56
Inhibition of Proteasomal Glucocorticoid Receptor Degradation Restores Dexamethasone-Mediated Stabilization of the Blood–Brain Barrier After Traumatic Brain Injury*
Thal, S. C., Schaible, E., Neuhaus, W., Scheffer, D., Brandstetter, M., Engelhard, K., Wunder, C., & Förster, C. Y. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827ca494 · Cited by 54
Aberrant Collagen Composition of the Trabecular Meshwork Results in Reduced Aqueous Humor Drainage and Elevated IOP in MMP-9 Null Mice
Groef, L. D., Andries, L., Siwakoti, A., Geeraerts, E., Bollaerts, I., Noterdaeme, L., Etienne, I., Papageorgiou, A., Stalmans, I., BILLEN, J. P. J., et al. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19734 · Cited by 54
Role of matrix metalloproteinase‐9 (MMP‐9) in striatal blood–brain barrier disruption in a 3‐nitropropionic acid model of Huntington's disease
Duran‐Vilaregut, J., del Valle, J., Manich, G., Camins, A., Pallàs, M., Vilaplana, J., & Pelegrí, C. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01157.x · Cited by 54
The executioners sing a new song: killer caspases activate microglia
Venero, J. L., Burguillos, M. Á., Brundin, P., & Joseph, B. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.107 · Cited by 55
Endogenous and synthetic MMP inhibitors in CNS physiopathology.
Baranger, K., Rivera, S., Liechti, F. D., Grandgirard, D., Bigas, J., Seco, J., Tarrago, T., Leib, S. L., & Khrestchatisky, M. (2014) · Progress in Brain Research · doi:10.1016/b978-0-444-63486-3.00014-1 · Cited by 52
Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations
Girard, R., Zeineddine, H. A., Fam, M. D., Mayampurath, A. M., Cao, Y. J., Shi, C., Shenkar, R., Polster, S. P., Jesselson, M., Duggan, R., et al. (2017) · Translational Stroke Research · doi:10.1007/s12975-017-0561-3 · Cited by 51
Looking for novel, brain-derived, peripheral biomarkers of neurological disorders
Chmielewska, N., Szyndler, J., Makowska, K., Wojtyna, D., Maciejak, P., & Płaźnik, A. (2018) · Neurologia i Neurochirurgia Polska · doi:10.1016/j.pjnns.2018.02.002 · Cited by 55
Apitherapy for Parkinson’s Disease: A Focus on the Effects of Propolis and Royal Jelly
Ali, A. M., & Kunugi, H. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1727142 · Cited by 52
Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis
Struyfs, H., Niemantsverdriet, E., Goossens, J., Fransén, E., Martin, J., Deyn, P. P. D., & Engelborghs, S. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00138 · Cited by 53
MMP-9 Inhibitor SB-3CT Attenuates Behavioral Impairments and Hippocampal Loss after Traumatic Brain Injury in Rat
Jia, F., Yin, Y.-H., Gao, G.-Y., Wang, Y., Cen, L., & Jiang, J.-Y. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2013.3230 · Cited by 49
In Vitro Cerebrovascular Modeling in the 21st Century: Current and Prospective Technologies
Palmiotti, C. A., Prasad, S., Naik, P. U., Kaisar, M. A., Sajja, R. K., Achyuta, A. H., & Cucullo, L. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1464-6 · Cited by 56
Role of MMP-2, MMP-7, MMP-9 and TIMP-2 in the development of recurrent depressive disorder
Bobińska, K., Szemraj, J., Czarny, P. L., & Gałecki, P. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.03.068 · Cited by 54
Tea polyphenols ameliorates neural redox imbalance and mitochondrial dysfunction via mechanisms linking the key circadian regular Bmal1
Qi, G., Mi, Y., Fan, R., Zhao, B., Ren, B., & Liu, X. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.10.031 · Cited by 55
Mesoporous silicon photonic crystal microparticles: towards single-cell optical biosensors
Guan, B., Magenau, A., Kilian, K. A., Ciampi, S., Gaus, K., Reece, P. J., & Gooding, J. J. (2010) · Faraday Discussions · doi:10.1039/c005340f · Cited by 51
Interrelationship between activation of matrix metalloproteinases and mitochondrial dysfunction in the development of diabetic retinopathy
dos Santos, J. M., Tewari, S., Lin, J. Y., & Kowluru, R. A. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.07.066 · Cited by 50
Proteolytic processing of Neuregulin-1
Willem, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.07.003 · Cited by 52
Red Grape Skin Polyphenols Blunt Matrix Metalloproteinase-2 and -9 Activity and Expression in Cell Models of Vascular Inflammation: Protective Role in Degenerative and Inflammatory Diseases
Calabriso, N., Massaro, M., Scoditti, E., Pellegrino, M., Ingrosso, I., Giovinazzo, G., & Carluccio, M. A. (2016) · Molecules · doi:10.3390/molecules21091147 · Cited by 50
Peroxynitrite decomposition catalyst prevents matrix metalloproteinase-9 activation and neurovascular injury after hemoglobin injection into the caudate nucleus of rats
Ding, R., Feng, L., He, L., Chen, Y., Wen, P., Fu, Z., Lin, C., Yang, S., Deng, X., Zeng, J., et al. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.065 · Cited by 49
Matrix metalloproteinases-2 and -3 are reduced in cerebrospinal fluid with low beta-amyloid1–42 levels
Mlekusch, R., & Humpel, C. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.09.043 · Cited by 49
Hypoxia-inducible factor-1α is involved in isoflurane-induced blood-brain barrier disruption in aged rats model of POCD
Cao, Y., Li, Z., Li, H., Ni, C., Li, L., Yang, N., Shi, C., Zhong, Y., Cui, D., & Guo, X. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.09.004 · Cited by 49
Single-cell analysis of dorsal root ganglia reveals metalloproteinase signaling in satellite glial cells and pain
Tonello, R., Prudente, A. S., Lee, S. H., Cohen, C. F., Xie, W., Paranjpe, A., Roh, J., Park, C., Chung, G., Strong, J. A., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.08.005 · Cited by 49
Matrix Metalloproteinase 2 (MMP-2) Degrades Soluble Vasculotropic Amyloid-β E22Q and L34V Mutants, Delaying Their Toxicity for Human Brain Microvascular Endothelial Cells
Hernández‐Guillamón, M., Mawhirt, S. L., Fossati, S., Blais, S. P., Parés, M., Peñalba, A., Boada, M., Couraud, P., Neubert, T. A., Montaner, J., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.135228 · Cited by 49
Elucidating Conserved Transcriptional Networks Underlying Pesticide Exposure and Parkinson's Disease: A Focus on Chemicals of Epidemiological Relevance
Cao, F., Souders, C. L., Perez‐Rodriguez, V., & Martyniuk, C. J. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2018.00701 · Cited by 48
Time-dependent dual effect of microglia in ischemic stroke
Fan, P., Wang, S., Chu, S., & Chen, N. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105584 · Cited by 49
Microcystin-Leucine Arginine Causes Cytotoxic Effects in Sertoli Cells Resulting in Reproductive Dysfunction in Male Mice
Chen, Y., Zhou, Y., Wang, J., Wang, L., Xiang, Z., Li, D., & Han, X. (2016) · Scientific Reports · doi:10.1038/srep39238 · Cited by 47
The Diverse Roles of TIMP-3: Insights into Degenerative Diseases of the Senescent Retina and Brain
Dewing, J. M., Carare, R. O., Lotery, A. J., & Ratnayaka, J. A. (2019) · Cells · doi:10.3390/cells9010039 · Cited by 46
Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse
Copin, J., Bengualid, D. J., da Silva, R., Kargiotis, O., Schaller, K., & Gasche, Y. G. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07843.x · Cited by 46
Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex
Li, S., Yu, S., Zhang, C., Shu, H., Liu, S., An, N., Yang, M., Yin, Q., & Yang, H. (2012) · Brain Research · doi:10.1016/j.brainres.2012.03.009 · Cited by 48
Theoretic, Experimental, Clinical Bases of the Water Oscillator Hypothesis in Near-Infrared Photobiomodulation
Santana‐Blank, L. A., Rodríguez–Santana, E., & Santana‐Rodríguez, K. E. (2010) · Photomedicine and Laser Surgery · doi:10.1089/pho.2009.2647 · Cited by 46
Matrix metalloproteinases and their tissue inhibitors in cuprizone-induced demyelination and remyelination of brain white and gray matter
Škuljec, J., Gudi, V., Ulrich, R., Frichert, K., Yildiz, Ö., Pul, R., Voss, E. V., Wissel, K., Baumgärtner, W., & Stangel, M. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182294fad · Cited by 49
Polyphenols from the stems of Morus alba and their inhibitory activity against nitric oxide production by lipopolysaccharide-activated microglia
Rivière, C., Krisa, S., Péchamat, L., Nassra, M., Delaunay, J.-C., Marchal, A., Badoc, A., Waffo‐Téguo, P., & Mérillon, J. (2014) · Fitoterapia · doi:10.1016/j.fitote.2014.06.001 · Cited by 45
Distinct roles for metalloproteinases during traumatic brain injury
Zhang, S., Kojic, L., Tsang, M., Grewal, P. S., Liu, J., Namjoshi, D., Wellington, C. L., Tetzlaff, W., Cynader, M. S., & Jia, W. W.-G. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.02.013 · Cited by 45
Multifunctional Hybrid Sulfonamides as Novel Therapeutic Agents for Alzheimer’s Disease
Swetha, R., Kumar, D., Gupta, S. K., Ganeshpurkar, A., Singh, R., Gutti, G., Kumar, D., Jana, S., Krishnamurthy, S., & Singh, S. K. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0106 · Cited by 46
S100B blood levels and childhood trauma in adolescent inpatients
Falcone, T., Janigro, D., Lovell, R. E., Simon, B., Brown, C. A., Herrera, M., Myint, A.-M., & Anand, A. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.12.002 · Cited by 44
INtensive versus Standard Ambulatory Blood Pressure Lowering to Prevent Functional DeclINe In The ElderlY (INFINITY)
White, W. B., Marfatia, R., Schmidt, J., Wakefield, D. B., Kaplan, R. F., Bohannon, R. W., Hall, C. B., Guttmann, C. R. G., Moscufo, N., Fellows, D., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2012.11.008 · Cited by 47
Matrix metalloproteinase-2 and −9 contribute to functional integrity and noise-induced damage to the blood-labyrinth-barrier
Wu, J., Han, W., Chen, X., Guo, W., Liu, K., Wang, R., Zhang, J., & Sai, N. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6784 · Cited by 44
Identification of Novel Alzheimer’s Disease Loci Using Sex-Specific Family-Based Association Analysis of Whole-Genome Sequence Data
Prokopenko, D., Hecker, J., Kirchner, R., Chapman, B., Hofmann, O., Mullin, K., Hide, W., Bertram, L., Laird, N. M., DeMeo, D. L., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-61883-6 · Cited by 44
Inflammatory Proprotein Convertase-Matrix Metalloproteinase Proteolytic Pathway in Antigen-presenting Cells as a Step to Autoimmune Multiple Sclerosis
Shiryaev, S. A., Remacle, A. G., Savinov, A. Y., Chernov, A. V., Cieplak, P., Radichev, I., Williams, R. M., Shiryaeva, T. N., Gawlik, K., Postnova, T. I., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041244 · Cited by 44
The protective effect of berberine against neuronal damage by inhibiting matrix metalloproteinase-9 and laminin degradation in experimental autoimmune encephalomyelitis
Jiang, Y., Wu, A., Zhu, C., Pi, R., Chen, S., Liu, Y., Ma, L., Zhu, D., & Chen, X. (2013) · Neurological Research · doi:10.1179/1743132812y.0000000156 · Cited by 43
Protective effect of naringin on 3-nitropropionic acid-induced neurodegeneration through the modulation of matrix metalloproteinases and glial fibrillary acidic protein
Gopinath, K., & Sudhandiran, G. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0035 · Cited by 43

Authors: Rosenberg, G. A.
Affiliations: University of New Mexico (US)
Corresponding author: Rosenberg, Gary A
ORCID: Rosenberg, Gary A
Venue: The Lancet Neurology
Publisher: Elsevier BV
Published: 2009-02
Volume: 8
Issue: 2
Pages: 205-216
ISSN: 1474-4422 (ISSN-L)
DOI: 10.1016/s1474-4422(09)70016-x
OpenAlex: W2124054487
Cited by: 594
References: 107
Citations by year: 2026: 27 · 2025: 23 · 2024: 18 · 2023: 34 · 2022: 33 · 2021: 35 · 2020: 29 · 2019: 28 · 2018: 22 · 2017: 34 · 2016: 33 · 2015: 52 · 2014: 54 · 2013: 47 · 2012: 37
FWCI: 2.62
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of Neurological Disorders and Stroke (R01NS045847, R01NS052305)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: matrix metalloproteinases, ADAMS, neuroinflammation, neurodegenerative diseases, blood-brain barrier permeability, tissue inhibitors of metalloproteinases, matrix metalloproteinase inhibitors, Alzheimer's disease, amyloid, Parkinson's disease, dopaminergic neurons, vascular cognitive impairment, white matter injury, angiogenesis, neurogenesis, signal transduction
MeSH terms: Humans, Inflammation, Protease Inhibitors, Neurodegenerative Diseases, Matrix Metalloproteinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Matrix metalloproteinases and their multiple roles in neurodegenerative diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks